<?xml version="1.0" encoding="UTF-8"?>
<urlset
      xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
      xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9
            http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">


<url>
  <loc>https://www.ocvpartners.com/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>1.00</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/about-us/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/team/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/portfolio/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/news/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/contact/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/careers/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/ocv-testimonials/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/byheart-completes-largest-us-clinical-trial-for-a-new-infant-formula-brand-in-the-last-25-years-supporting-their-innovation-in-baby-nutrition/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/orca-ai-which-puts-computer-vision-onto-cargo-ships-raises-13m-series-a-funding/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/finch-therapeutics-announces-pricing-of-upsized-initial-public-offering/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/privacy-policy/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/terms-of-use/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/richard-ressler/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/hemi-zucker/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/zohar-loshitzer/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/chris-bostick/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/steph-janson/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/eli-cole/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/camella-wilson/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/praxis-precision-medicines-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/ossio-awarded-fda-510k-clearance-for-ossiofiber-compression-screw-portfolio/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/ocv-partners-assist-portfolio-company-social-native-in-acquiring-olapic-to-create-next-gen-creative-optimization-platform/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/ocv-partners-participates-in-finch-therapeutics-oversubscribed-90-million-financing-to-advance-its-pipeline-of-investigational-oral-microbiome-drugs/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/safebreach-raises-19-million-to-expand-channels-accelerate-product-development/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/ocv-partners-co-leads-by-hearts-70m-series-a-financing-ahead-of-first-product-launch-in-2021/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/ossio-receives-fda-510k-clearance-for-ossiofiber-hammertoe-fixation-system/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/finch-therapeutics-completes-enrollment-in-potentially-pivotal-trial-of-cp101-an-investigational-oral-full-spectrum-microbiota-therapy-for-the-prevention-of-recurrent-c-difficile-infection/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/finch-therapeutics-raises-53-million-to-advance-microbiome-based-therapies-for-recurrent-c-difficile-autism-and-other-disease-areas/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/news/page/2/?et_blog</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/category/news-updates/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/category/team/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/museum-of-ice-cream-founders-launch-figure8-with-series-a-to-transform-how-millennials-and-gen-z-connect-with-spaces-and-each-other/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/ossio-secures-22-million-in-financing/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/invoice2go-raises-10-million-attracting-new-and-existing-investors-and-hemi-zucker-from-ocv-partners-to-join-the-board-of-directors/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/precision-biosciences-raises-110m-to-advance-arcus-genome-editing-programs/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/hemi-zucker-to-join-ocv-management-as-managing-principal/</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.51</priority>
</url>
<url>
  <loc>https://www.ocvpartners.com/news/?et_blog</loc>
  <lastmod>2021-06-15T23:20:41+00:00</lastmod>
  <priority>0.51</priority>
</url>


</urlset>